Skip to main content
Log in

Intense pulse light therapy treatment for refractory dry eye disease due to meibomian gland dysfunction

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To assess the effect of the intense pulse light (IPL) therapy for the treatment of meibomian gland dysfunction (MGD) and dry eye parameters.

Methods

Patients who underwent an IPL therapy for the treatment of MGD were included in this retrospective study. Ocular Surface Disease Index (OSDI) scores, the frequency of daily lubricant use, non-invasive tear break-up time (NIBUT), meibomian glad dropout scores, corneal staining scores, and Schirmer test results were collected from patient charts that recorded at baseline and follow-up visits at 1 month, 3 months, and 12 months. For the analysis, patients were grouped based on the severity of their baseline meibomian gland dropout score as mild, moderate, and severe atrophy.

Results

Forty-three patients (mild atrophy = 22, moderate atrophy = 17, and severe atrophy = 4) were included for analysis. Except for the Schirmer test, all dry eye parameters significantly improved in patients with mild and moderate atrophy following the treatment and this effect lasted until the 12-month follow-up visit (p < 0.001). No significant improvement in any parameter was observed in patients with severe atrophy at any time point (p > 0.05). In the mild and moderate atrophy groups, OSDI scores, as well as NIBUT, started improving at 1 month (p < 0.01), while corneal staining and meibomian gland dropout scores showed earliest improvements at 3 months (p < 0.01). No adverse events were observed, except for temporary redness in 4 patients.

Conclusion

The IPL treatment seems an effective and safe treatment for patients with MGD. This study shows that the IPL resulting in an earlier improvement in symptoms and signs with long-lasting beneficial effect on the meibomian glands.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ding J, Sullivan DA (2012) Aging and dry eye disease. Exp Gerontol 47:483–490

    Article  Google Scholar 

  2. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, Foulks GN (2011) The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 52:1930–1937

    Article  Google Scholar 

  3. Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR et al (2012) A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea 31(4):396–404

    Article  Google Scholar 

  4. Toyos R, McGill W, Briscoe D (2015) Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study. Photomed Laser Surg 33:41–46

    Article  Google Scholar 

  5. Gupta PK, Vora GK, Matossian C, Kim M, Stinnett S (2016) Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease. Can J Ophthalmol 51:249–253

    Article  Google Scholar 

  6. Vegunta S, Patel D, Shen JF (2016) Combination therapy of intense pulsed light therapy and meibomian gland expression (IPL/MGX) can improve dry eye symptoms and meibomian gland function in patients with refractory dry eye: a retrospective analysis. Cornea 35:318–322

    Article  Google Scholar 

  7. Craig JP, Chen YH, Turnbull PR (2015) Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 56:1965–1970

    Article  Google Scholar 

  8. Yin Y, Liu N, Gong L, Song N (2018) Changes in the meibomian gland after exposure to intense pulsed light in meibomian gland dysfunction (MGD) patients. Curr Eye Res 43:308–313

    Article  Google Scholar 

  9. Albietz JM, Schmid KL (2018) Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction. Clin Exp Optom 101:23–33

    Article  Google Scholar 

  10. Vora GK, Gupta PK (2015) Intense pulsed light therapy for the treatment of evaporative dry eye disease. Curr Opin Ophthalmol 26:314–318

    Article  Google Scholar 

  11. Walt J (2004) Ocular Surface Disease Index (OSDI) administration and scoring manual. Allergan Inc., Irvine

    Google Scholar 

  12. Bron AJ, Evans VE, Smith JA (2003) Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22:640–650

    Article  Google Scholar 

  13. Gupta PK, Stevens MN, Kashyap N, Priestley Y (2018) Prevalence of meibomian gland atrophy in a pediatric population. Cornea 37:426–430

    Article  Google Scholar 

  14. Kang YS, Lee HS, Li Y, Choi W, Yoon KC (2018) Manifestation of meibomian gland dysfunction in patients with Sjögren’s syndrome, non-Sjögren’s dry eye, and non-dry eye controls. Int Ophthalmol 38:1161–1167

    Article  Google Scholar 

  15. Fitzpatrick TB (1988) The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124:869–871

    Article  CAS  Google Scholar 

  16. Dell SJ, Gaster RN, Barbarino SC, Cunningham DN (2017) Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction. Clin Ophthalmol 11:817–827

    Article  CAS  Google Scholar 

  17. Seo KY, Kang SM, Ha DY, Chin HS, Jung JW (2018) Long-term effects of intense pulsed light treatment on the ocular surface in patients with rosacea-associated meibomian gland dysfunction. Contact Lens Anterior Eye 41:430–435

    Article  Google Scholar 

  18. Arita R, Mizoguchi T, Fukuoka S, Morishige N (2018) Multicenter study of intense pulsed light therapy for patients with refractory meibomian gland dysfunction. Cornea 37:1566–1571

    Article  Google Scholar 

  19. Dell SJ (2017) Intense pulsed light for evaporative dry eye disease. Clin Ophthalmol 11:1167–1173

    Article  CAS  Google Scholar 

  20. Karaca EE, Evren Kemer O, Ozek D (2018) Intense regulated pulse light for the meibomian gland dysfunction. Eur J Ophthalmol, p 1120672118817687. 4 Dec 2018 [Online ahead of print]

  21. Messmer EM (2015) The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int 112:71–81

    PubMed  PubMed Central  Google Scholar 

Download references

Funding

Intense pulse light dry eye treatment platform was provided by Espansione group (Bologna, Italy) for the duration of the study. The funding organization had no role in the design or conduct of this research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Osman Bulut Ocak.

Ethics declarations

Conflict of interest

No conflicting relationship exists for any author.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yurttaser Ocak, S., Karakus, S., Ocak, O.B. et al. Intense pulse light therapy treatment for refractory dry eye disease due to meibomian gland dysfunction. Int Ophthalmol 40, 1135–1141 (2020). https://doi.org/10.1007/s10792-019-01278-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-019-01278-3

Keywords

Navigation